Hematologic Malignancy Information for Medical Professionals
University Hospitals Seidman Cancer Center in Cleveland, Ohio focuses on improving and extending the lives of patients with hematologic malignancies, including leukemia, lymphoma, and myeloma, by offering an array of resources and programs for clinicians who both want to understand more about our program’s offerings, as well as continue their education in the field through our fellowships and training programs.
Learn more about our programs and referral methods
- Leukema
-
The leukemia team at University Hospitals Seidman Cancer Center in Cleveland, Ohio focuses on improving and extending the lives of leukemia patients with excellent clinical care and the development of new and improved treatments. From diagnosis and treatment – including stem cell transplant if necessary – through survivorship, our team supports patients at every step during their care journey. Our nationally recognized researchers and clinicians are at the forefront of leukemia research and discovery, making important discoveries in advancing the diagnosis and treatment of the disease.
Referrals and Consultations
To refer a patient or schedule a consultation with a leukemia specialist, contact our malignant hematology nurse navigator for UH Seidman Cancer Center at 216-286-6537.
Patients can also be referred to our main UH Seidman Cancer Center scheduling number at 216-844-3951.
- Multiple Myeloma
-
Our team delivers state-of-the-art disease management with a multidisciplinary approach, integrating the latest medical technologies, minimally invasive therapies and research. From diagnosis through treatment and ongoing myeloma management, including stem cell transplant if needed, the same clinical team directs and follows each patient’s care.
Clinical Trials for Multiple Myeloma Patients
At UH Seidman Cancer Center, our physician-scientists are engaged in advancing medicine through research and discovery. With access to myeloma-specific clinical trials, our patients can benefit from the latest therapies, including:
- Monoclonal antibodies for targeted anti-myeloma therapy
- Minimal residual disease (MRD) detection
- Other immunotherapies
Our experts leverage the most recent advances in multiple myeloma care to make treatment safer, more tolerable and more effective for patients.
Referrals and Consultations
To refer a patient or schedule a consultation with a multiple myeloma specialist, contact our malignant hematology nurse navigator for UH Seidman Cancer Center at 216-286-6537.
Patients can also be referred to our main UH Seidman Cancer Center scheduling number at 216-844-3951.
Patient Care
Learn more about how UH Seidman Cancer Center provides care for patients with hematologic malignancies.
Download the UH Provider App
